August 10, 2022 at 08:07PM Variant Creutzfeldt-Jakob Disease (vCJD) and Plasma Derivatives Other than Factor VIII (pdFVIII) Questions and Answers

The US Public Health Service, including FDA, CDC, and NIH, believes that vCJD risk from US licensed pdFVIII products is most likely to be extremely small, although we do not know the risk with certainty.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/CjDIeKS